FDA approves drug for early breast cancer
208946
The Food and Drug Administration agreed Friday to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
411375
GlaxoSmithKline Plc  won U.S. approval for a once-a-day breast cancer pill on Tuesday that the drugmaker hopes will launch a new era for its oncology business.
251574
U.S. health regulators have approved GlaxoSmithKline Plc's   pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.
133597
TUESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved a test designed to predict the chances of breast cancer returning or spreading within five to 10 years after a woman's initial cancer.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
367403
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
556150
TUESDAY, Jan. 30 (HealthDay News) -- A compound designed to block growth hormone, coupled with a standard chemotherapy drug, successfully treated human breast cancer in mice.
62192
Arimidex has been shown to reduce the recurrence of breast cancer in women better than tamoxifen, the standard breast cancer therapy for postmenopausal women.
353967
A new drug is better than tamoxifen at preventing breast cancers from coming back and should immediately become the first-line treatment for women with certain tumours, researchers say.
455559
Doctors researching breast cancer say a new drug has had "exciting" results.
262390
A NEWER drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors in the US said yesterday, citing a new study.
167586
SAN ANTONIO -- A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
399257
WASHINGTON - U.S. health officials approved a genetic test on Tuesday that can give women with early breast cancer an estimate of whether the disease is likely to return in five to 10 years.
554059
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.
14
A new type of drug shows growing promise as a more potent way for many breast cancer patients to significantly cut their risk of a recurrence, researchers reported yesterday.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
597488
The U.S. Food and Drug  Administration said on Monday it had approved Cephalon Inc.'s  drug Fentora to treat pain in certain cancer patients.